Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12462210 | 0.95 | ALDH1A1 (0.45) | — | |
| SCHEMBL14715889 | 0.95 | ALDH1A1 (0.45) | — | |
| SCHEMBL6263292 | 0.91 | DNM1 (0.39) | — | |
| SCHEMBL2519902 | 0.91 | DNM1 (0.39) | — | |
| SCHEMBL935452 | 0.90 | ALDH1A1 (0.41) | — | |
| Trimethylammonium SCHEMBL3917836 | 0.81 | LPAR2 (0.42) | LPAR2LPAR3LPAR1FAAHTRPV1 | |
| SCHEMBL18184028 | 0.80 | LPAR2 (0.50) | LPAR2LPAR3LPAR1FAAHTRPV1 | |
| SCHEMBL16311960 | 0.80 | LPAR2 (0.50) | LPAR2LPAR3LPAR1FAAHTRPV1 | |
| SCHEMBL28438320 | 0.79 | CNR1 (0.42) | LPAR2LPAR3LPAR1FAAHTRPV1 | |
| SCHEMBL6831358 | 0.76 | LPAR2 (0.44) | LPAR2LPAR3LPAR1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119074-A1 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO. (US) | 2024-06-06 | — | — | WO | claimed |
| CN-118043068-A | RNA vaccine | 阿克丘勒斯治疗公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2019161263-A1 | LIPID-SURFACTANT NANOPARTICLES FOR DRUG DELIVERY AND METHODS OF MAKING AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-22 | — | — | WO | claimed |
| EP-3247328-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PhaseRx, Inc. (US) | 2017-11-29 | — | — | EP | claimed |
| WO-2016118697-A9 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-09-29 | — | — | WO | claimed |
| WO-2016118697-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-07-28 | — | — | WO | claimed |
| EP-4370135-A2 | SINGLE CHAIN VARIABLE FRAGMENT (SCFV) MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | Generation Bio Co. (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-118043068-A | RNA vaccine | 阿克丘勒斯治疗公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-4181948-A2 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | Generation Bio Co. (US) | 2023-05-24 | — | — | EP | disclosed |
| WO-2023069628-A2 | COMPOSITIONS AND METHODS FOR SILENCING KRAS | NANOTHERA BIOSCIENCES, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023287861-A2 | SINGLE CHAIN VARIABLE FRAGMENT (SCFV) MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | GENERATION BIO CO. (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2022016089-A2 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | GENERATION BIO CO. (US) | 2022-01-20 | — | — | WO | disclosed |
| EP-3934700-A1 | NON-ACTIVE LIPID NANOPARTICLES WITH NON-VIRAL, CAPSID FREE DNA | Generation Bio Co. (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3247328-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PhaseRx, Inc. (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2016118697-A9 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2016118697-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-07-28 | — | — | WO | disclosed |
| EP-2350043-A1 | IMPROVED AMINO LIPIDS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS | TEKMIRA Pharmaceuticals Corporation (CA) | 2011-08-03 | — | — | EP | disclosed |
| EP-2224912-A1 | IMPROVED COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS | TEKMIRA Pharmaceuticals Corporation (CA) | 2010-09-08 | — | — | EP | disclosed |
| WO-2010042877-A1 | IMPROVED AMINO LIPIDS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS | TEKMIRA PHARMACEUTICALS CORPORATION (CA) | 2010-04-15 | — | — | WO | disclosed |
| WO-2009086558-A1 | IMPROVED COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS | TEKMIRA PHARMACEUTICALS CORPORATION (CA) | 2009-07-09 | — | — | WO | disclosed |